Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Philen

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Seminars in Arthritis and Rheumatism|October 1, 1993
Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting reportR M Philen, M Posada
Mayo Clinic Proceedings|February 1, 1993
3-(Phenylamino)alanine--a link between eosinophilia-myalgia syndrome and toxic oil syndrome?R M Philen, R H Hill
Drug Safety|February 1, 1993
Tryptophan. Current status and future trends for oral administrationL D Kaufman, R M Philen
The Journal of Rheumatology|October 1, 1996
Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic casesE A Sullivan, N Staehling, R M Philen
The American Journal of Clinical Nutrition|September 1, 1996
Nothing's simple about malnutrition: complexities raised by epidemic neuropathy in CubaB A Bowman, C Bern, R M Philen
Archives of Internal Medicine|April 28, 1997
Chaparral-associated hepatotoxicityN M Sheikh, R M Philen, L A Love
JAMA|August 26, 1992
Survey of advertising for nutritional supplements in health and bodybuilding magazinesR M Philen, D I Ortiz, S B Auerbach, et al.
Journal of Medicinal Chemistry|November 1, 1977
Synthsis and antitumor properties of bis(quinaldine) derivativesB K Sinha, R M Philen, R Sato, et al.
The Journal of Rheumatology. Supplement|October 1, 1996
Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndromeE M Kilbourne, R M Philen, M L Kamb, et al.
Epidemiologic Reviews|August 24, 2002
Toxic oil syndrome: the perspective after 20 yearsM Posada de la Paz, R M Philen, A I Borda
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Seminars in Arthritis and Rheumatism|October 1, 1993
Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting reportR M Philen, M Posada
Mayo Clinic Proceedings|February 1, 1993
3-(Phenylamino)alanine--a link between eosinophilia-myalgia syndrome and toxic oil syndrome?R M Philen, R H Hill
Drug Safety|February 1, 1993
Tryptophan. Current status and future trends for oral administrationL D Kaufman, R M Philen
The Journal of Rheumatology|October 1, 1996
Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic casesE A Sullivan, N Staehling, R M Philen
The American Journal of Clinical Nutrition|September 1, 1996
Nothing's simple about malnutrition: complexities raised by epidemic neuropathy in CubaB A Bowman, C Bern, R M Philen
Archives of Internal Medicine|April 28, 1997
Chaparral-associated hepatotoxicityN M Sheikh, R M Philen, L A Love
JAMA|August 26, 1992
Survey of advertising for nutritional supplements in health and bodybuilding magazinesR M Philen, D I Ortiz, S B Auerbach, et al.
Journal of Medicinal Chemistry|November 1, 1977
Synthsis and antitumor properties of bis(quinaldine) derivativesB K Sinha, R M Philen, R Sato, et al.
The Journal of Rheumatology. Supplement|October 1, 1996
Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndromeE M Kilbourne, R M Philen, M L Kamb, et al.
Epidemiologic Reviews|August 24, 2002
Toxic oil syndrome: the perspective after 20 yearsM Posada de la Paz, R M Philen, A I Borda
Pageof 4